HB 263 Delaware House · 150th General Assembly (2019-2020)

AN ACT TO AMEND TITLE 18 AND TITLE 29 OF THE DELAWARE CODE RELATING TO COST SHARING IN PRESCRIPTION INSULIN DRUGS.

Summary
This Act requires that individual, group, and State employee insurance plans cap the amount an individual must pay for insulin prescriptions at $100 a month and must include at least 1 formulation of insulin on the lowest tier of the drug formulary developed and maintained by the carrier.
Bill status signed all 5 stages cleared
Introduction
Jan 2020
Committee Review
Jan 2020
House Passage
Jan 2020
Senate Passage
Jun 2020
Signed into Law
Jul 2020
Introduced Jan 9, 2020 Signed Jul 16, 2020
Floor votes · House Jan 30, 2020

How they voted

This bill passed the Senate by voice vote (no roll call recorded).
Full legislative history

Actions timeline

Total actions
11
Key actions
5
Committee
1
Amendments
4
Jul 16, 2020
Signed into law
Signed by Governor
executive
Jun 16, 2020
Upper · Passed
Passed By Senate. Votes: 21 YES
upper
Feb 28, 2020
Introduced
Assigned to Health & Social Services Committee in Senate
upper
Jan 30, 2020
Lower · Passed
Passed By House. Votes: 40 YES 1 ABSENT
lower
Jan 30, 2020
Introduced
Amendment HA 2 to HB 263 - Stricken in House
lower
Jan 30, 2020
Lower · Passed
Amendment HA 1 to HB 263 - Passed In House by Voice Vote
lower
Jan 29, 2020
Introduced
Amendment HA 2 to HB 263 - Introduced and Placed With Bill
lower
Jan 29, 2020
Introduced
Amendment HA 1 to HB 263 - Introduced and Placed With Bill
lower
Jan 15, 2020
Lower · Passed
Reported Out of Committee (Health & Human Development) in House with 5 Favorable, 4 On Its Merits
lower
Jan 9, 2020
Introduced
Introduced and Assigned to Health & Human Development Committee in House
lower
6 primary · 22 co-sponsors

Sponsors